#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	324	CRP	633	633	99.37	CRP.l15.c30.ctg.1	1080	16.0	0	.	p	.	0	K29T	NONSYN	85	87	AAG	281	283	ACG	20;20;20	A;C;G	19;20;20	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	324	CRP	633	633	99.37	CRP.l15.c30.ctg.1	1080	16.0	0	.	p	.	0	S118P	NONSYN	352	354	TCT	548	550	CCT	23;24;24	C;C;T	23;24;24	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	172	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	209	8.8	0	.	n	.	0	T879G	SNP	879	879	T	69	69	G	2	G	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	172	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	209	8.8	0	.	n	.	0	G880A	SNP	880	880	G	70	70	A	2	A	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	172	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	209	8.8	0	.	n	.	0	A888G	SNP	888	888	A	78	78	G	4	G	4	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	172	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	209	8.8	0	.	n	.	0	C897G	SNP	897	897	C	87	87	G	6	G	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	172	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	209	8.8	0	.	n	.	0	T898C	SNP	898	898	T	88	88	C	6	C	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	172	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	209	8.8	0	.	n	.	0	G906T	SNP	906	906	G	96	96	T	8	T	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	172	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	209	8.8	0	.	n	.	0	G908A	SNP	908	908	G	98	98	A	8	A	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	172	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	209	8.8	0	.	n	.	0	A918T	SNP	918	918	A	108	108	T	12	T	12	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	172	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	209	8.8	0	.	n	.	0	A943G	SNP	943	943	A	133	133	G	26	G	26	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	172	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	209	8.8	0	.	n	.	0	G991T	SNP	991	991	G	181	181	T	14	T	14	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	167	1116	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1201	43.9	0	HET	.	.	.	C954T	.	954	954	C	991	991	C	41	C,T	23,17	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	167	1116	Escherichia_coli_EF_Tu	1185	66	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.5	190	6.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	370	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1789	11.1	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1579	1581	AAA	4;3;2	A;A;A	4;3;2	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	480	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l6.c17.ctg.1	1592	15.9	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1209	1211	GAA	14;14;14	G;A;A	14;14;14	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	136	H_NS	414	414	99.03	H_NS.l6.c4.ctg.1	794	9.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	T1041G	SNP	1041	1041	T	13	13	G	57	G	37	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	A1042T	SNP	1042	1042	A	14	14	T	62	T	42	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	A1136G	SNP	1136	1136	A	108	108	G	80	G	80	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	T1138C	SNP	1138	1138	T	110	110	C	74	C	74	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	T1142C	SNP	1142	1142	T	114	114	C	67	C	67	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	C1170T	SNP	1170	1170	C	142	142	T	68	T	68	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	T1220C	SNP	1220	1220	T	192	192	C	90	C	90	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	T1245C	SNP	1245	1245	T	217	217	C	61	C	61	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	G1253A	SNP	1253	1253	G	225	225	A	57	A	57	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	G1256A	SNP	1256	1256	G	228	228	A	55	A	55	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	C1258A	SNP	1258	1258	C	230	230	A	56	A	56	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	G1266T	SNP	1266	1266	G	238	238	T	59	T	59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	T1267C	SNP	1267	1267	T	239	239	C	57	C	57	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	T1275C	SNP	1275	1275	T	247	247	C	51	C	51	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	G1276A	SNP	1276	1276	G	248	248	A	51	A	51	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	A1281G	SNP	1281	1281	A	253	253	G	49	G	49	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	T1283C	SNP	1283	1283	T	255	255	C	51	C	51	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	G1288T	SNP	1288	1288	G	260	260	T	56	T	56	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	A1296G	SNP	1296	1296	A	268	268	G	70	G	70	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	T1299G	SNP	1299	1299	T	271	271	G	77	G	77	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	A1300T	SNP	1300	1300	A	272	272	T	76	T	76	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	C1356T	SNP	1356	1356	C	328	328	T	80	T	80	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	A1358G	SNP	1358	1358	A	330	330	G	79	G	79	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	T1368C	SNP	1368	1368	T	340	340	C	65	C	65	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	G1370A	SNP	1370	1370	G	342	342	A	60	A	59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	C1406.	DEL	1406	1406	C	377	377	C	37	C	37	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	.1409C	INS	1409	1409	T	381	381	C	36	C	36	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	C1431A	SNP	1431	1431	C	403	403	A	8	A	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	C1432A	SNP	1432	1432	C	404	404	A	8	A	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	A1441G	SNP	1441	1441	A	413	413	G	8	G	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	T1464C	SNP	1464	1464	T	436	436	C	15	C	15	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	G1473T	SNP	1473	1473	G	445	445	T	29	T	29	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	A1475G	SNP	1475	1475	A	447	447	G	36	G	36	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	0	.	n	.	0	A1548T	SNP	1548	1548	A	520	520	T	27	T	27	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	1494	Pasteurella_multocida_16S	1551	523	91.6	Pasteurella_multocida_16S.l15.c30.ctg.1	713	55.5	1	SNP	n	C1194G	0	.	.	1194	1194	C	166	166	C	90	C	90	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	412	PmrB_1	1092	1092	99.27	PmrB_1.l6.c4.ctg.1	1505	14.4	0	.	p	.	0	H2R	NONSYN	4	6	CAT	215	217	CGT	11;11;11	C;G;T	11;11;11	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	412	PmrB_1	1092	1092	99.27	PmrB_1.l6.c4.ctg.1	1505	14.4	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1058	1060	GGC	15;16;16	G;G;C	15;16;16	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	562	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1975	15.2	0	.	p	.	0	R8S	NONSYN	22	24	AGA	202	204	AGC	7;7;7	A;G;C	7;7;7	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	562	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1975	15.2	0	.	p	.	0	I142L	NONSYN	424	426	ATA	604	606	CTA	15;15;16	C;T;A	15;15;16	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	562	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1975	15.2	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1123	1125	CAA	21;22;22	C;A;A	21;22;22	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	562	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1975	15.2	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1222	1224	GGT	20;18;19	G;G;T	20;18;19	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	562	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1975	15.2	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1792	1794	GTT	13;13;13	G;T;T	13;13;13	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	282	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1431	10.5	0	.	p	.	0	A125E	NONSYN	373	375	GCA	562	564	GAA	13;13;12	G;A;A	13;13;12	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	282	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1431	10.5	0	.	p	.	0	M185T	NONSYN	553	555	ATG	742	744	ACC	5;5;5	A;C;C	5;5;5	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	282	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1431	10.5	0	.	p	.	0	S225T	NONSYN	673	675	TCC	862	864	ACT	9;9;9	A;C;T	9;9;9	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	282	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1431	10.5	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1252	1254	ATC	5;5;5	A;T;C	5;5;5	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	356	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1418	13.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	512	54	TEM_1+	858	114	99.12	TEM_1+.l15.c4.ctg.1	116	3.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-124;TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	512	54	TEM_1+	858	175	98.86	TEM_1+.l15.c4.ctg.2	175	4.3	0	.	p	.	0	V82I	NONSYN	244	246	GTT	160	162	ATT	1;1;1	A;T;T	1;1;1	.	TEM-124;TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	512	54	TEM_1+	858	138	98.55	TEM_1+.l15.c4.ctg.3	138	3.9	0	.	p	.	0	T180M	NONSYN	538	540	ACG	11	13	ATG	2;2;2	A;T;G	2;2;2	.	TEM-124;TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	512	54	TEM_1+	858	138	98.55	TEM_1+.l15.c4.ctg.3	138	3.9	0	.	p	.	0	A182V	NONSYN	544	546	GCA	17	19	GTA	2;2;2	G;T;A	2;2;2	.	TEM-124;TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1056	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3380	16.7	0	.	p	.	0	T85I	NONSYN	253	255	ACC	455	457	ATC	15;14;14	A;T;C	15;14;14	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1056	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3380	16.7	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2168	2170	AAG	15;16;16	A;A;G	15;16;16	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	438	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1496	15.6	0	.	p	.	0	A22V	NONSYN	64	66	GCC	218	220	GTC	5;5;5	G;T;C	5;5;5	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	438	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1496	15.6	0	.	p	.	0	S269C	NONSYN	805	807	AGC	959	961	TGC	13;13;12	T;G;C	13;13;12	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1070	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3332	16.8	0	.	p	.	0	S46trunc	TRUNC	136	136	T	167	167	T	6	T	6	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1070	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3332	16.8	0	.	p	.	0	G148D	NONSYN	442	444	GGC	473	475	GAC	19;19;18	G;A;C	19;19;18	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1070	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3332	16.8	0	.	p	.	0	F240L	NONSYN	718	720	TTT	749	751	TTA	12;11;11	T;T;A	12;11;11	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1070	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3332	16.8	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1826	1828	AAT	16;17;17	A;A;T	15;17;17	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1070	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3332	16.8	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	1940	1942	AGT	19;17;17	A;G;T	19;17;17	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1070	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3332	16.8	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2339	2341	GTG	22;23;23	G;T;G	22;23;23	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1070	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3332	16.8	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	2894	2896	AAG	15;17;16	A;A;G	14;17;15	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	268	acrR_2	648	648	99.54	acrR_2.l6.c4.ctg.1	1044	13.6	1	SNP	p	R45C	0	.	.	133	135	CGC	313	315	CGC	15;14;14	C;G;C	15;14;14	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	204	acrS	663	663	98.79	acrS.l6.c30.ctg.1	961	11.4	0	.	p	.	0	L34F	NONSYN	100	102	CTC	198	200	TTC	11;11;11	T;T;C	11;11;11	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	204	acrS	663	663	98.79	acrS.l6.c30.ctg.1	961	11.4	0	.	p	.	0	E122G	NONSYN	364	366	GAG	462	464	GGG	11;11;11	G;G;G	11;11;11	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	350	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1199	15.7	0	.	p	.	0	V136L	NONSYN	406	408	GTT	640	642	CTT	24;24;23	C;T;T	24;24;23	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1030	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	2996	18.4	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2038	2040	GCA	23;23;24	G;C;A	23;23;24	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1030	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	2996	18.4	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2299	2301	ACC	26;26;26	A;C;C	26;26;26	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1030	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	2996	18.4	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2608	2610	GCC	18;18;19	G;C;C	18;18;19	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	574	arnA_1	1983	1734	98.44	arnA_1.l6.c17.ctg.1	1795	15.3	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	16	18	TGC	3;3;3	T;G;C	3;3;3	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	574	arnA_1	1983	1734	98.44	arnA_1.l6.c17.ctg.1	1795	15.3	0	.	p	.	0	I150V	NONSYN	448	450	ATT	199	201	GTT	14;14;15	G;T;T	14;14;15	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	574	arnA_1	1983	1734	98.44	arnA_1.l6.c17.ctg.1	1795	15.3	0	.	p	.	0	R200H	NONSYN	598	600	CGC	349	351	CAC	9;8;8	C;A;C	9;8;8	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	574	arnA_1	1983	1734	98.44	arnA_1.l6.c17.ctg.1	1795	15.3	0	.	p	.	0	T295M	NONSYN	883	885	ACG	634	636	ATG	20;20;21	A;T;G	20;20;21	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	574	arnA_1	1983	1734	98.44	arnA_1.l6.c17.ctg.1	1795	15.3	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1630	1632	CGC	11;11;11	C;G;C	11;11;11	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	574	arnA_1	1983	238	97.06	arnA_1.l6.c17.ctg.2	297	8.1	0	.	p	.	0	G37A	NONSYN	109	111	GGT	168	170	GCT	2;2;3	G;C;T	2;2;3	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	574	arnA_1	1983	238	97.06	arnA_1.l6.c17.ctg.2	297	8.1	0	.	p	.	0	D77E	NONSYN	229	231	GAT	288	290	GAG	3;3;3	G;A;G	3;3;3	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	224	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1065	10.8	0	.	p	.	0	S221T	NONSYN	661	663	AGC	861	863	ACC	6;6;4	A;C;C	6;6;4	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	224	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1065	10.8	0	.	p	.	0	P225S	NONSYN	673	675	CCG	873	875	TCG	5;6;6	T;C;G	5;6;5	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	19	194	baeR	723	636	97.8	baeR.l6.c30.ctg.1	717	12.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	478	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1481	16.4	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1194	1196	AAA	8;8;8	A;A;A	8;8;8	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	478	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1481	16.4	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1206	1208	GAG	8;8;8	G;A;G	8;7;8	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	478	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1481	16.4	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1212	1214	CAC	9;9;8	C;A;C	8;8;8	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	478	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1481	16.4	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1266	1268	GAG	4;4;4	G;A;G	4;4;4	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	539	512	cpxA	1374	1374	98.76	cpxA.l15.c4.ctg.1	1638	16.2	0	.	p	.	0	A231T	NONSYN	691	693	GCG	711	713	ACG	17;15;15	A,G;C;G	15,1;14;14	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	310	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1106	15.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	336	cysB	975	975	99.28	cysB.l15.c30.ctg.1	1397	13.0	0	.	p	.	0	T132I	NONSYN	394	396	ACA	632	634	ATA	21;21;21	A;T;A	21;21;21	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	432	emrA	1173	1173	98.38	emrA.l15.c4.ctg.1	1700	13.6	0	.	p	.	0	I219V	NONSYN	655	657	ATC	936	938	GTC	17;16;16	G;T;C	17;16;15	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	648	emrB	1539	1539	99.81	emrB.l15.c30.ctg.1	2059	16.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	408	emrD	1191	1191	98.57	emrD.l15.c4.ctg.1	1692	12.9	0	.	p	.	0	G209S	NONSYN	625	627	GGC	883	885	AGC	10;9;9	A;G;C	10;9;9	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	348	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1458	12.7	0	.	p	.	0	K176R	NONSYN	526	528	AAG	723	725	AGG	11;11;12	A;G;G	11;10;12	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	348	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1458	12.7	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1113	1115	GAC	7;7;7	G;A;C	7;7;7	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	200	emrR	531	531	100.0	emrR.l15.c30.ctg.2	735	13.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	496	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1961	13.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	206	evgA	615	615	99.19	evgA.l15.c17.ctg.1	870	11.7	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	274	276	CTG	12;12;11	C;T;G	12;12;11	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	A93T	NONSYN	277	279	GCG	141	143	ACG	8;8;9	A;C;G	8;8;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	A114E	NONSYN	340	342	GCA	204	206	GAA	13;13;12	G;A;A	13;13;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	T127A	NONSYN	379	381	ACT	243	245	GCT	15;15;14	G;C;T	15;15;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	N133D	NONSYN	397	399	AAT	261	263	GAT	12;12;12	G;A;T	12;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	P162S	NONSYN	484	486	CCA	348	350	TCA	9;9;10	T;C;A	9;9;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	477	479	CAG	6;6;6	C;A;G	6;6;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	I251V	NONSYN	751	753	ATT	615	617	GTT	8;8;8	G;T;T	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	N303D	NONSYN	907	909	AAT	771	773	GAT	7;7;7	G;A;T	7;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	939	941	AAT	6;6;6	A;A;T	6;6;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	960	962	TTA	1;1;1	T;T;A	1;1;1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1161	1163	AAA	14;14;14	A;A;A	14;14;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	1896	1898	CAT	22;22;21	C;A;T	22;22;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	1950	1952	CAT	12;11;11	C;A;T	12;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1968	1970	AGA	9;9;9	A;G;A	9;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1983	1985	AAT	6;6;5	A;A;T	6;6;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2130	2132	TCC	9;8;7	T;C;C	9;8;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2295	2297	ATT	8;7;7	A;T;T	8;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2316	2318	GAT	6;5;5	G;A;T	6;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2430	2432	GTT	14;14;14	G;T;T	14;14;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	3458	97.51	evgS.l6.c30.ctg.1	3594	15.4	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	2715	2717	CAC	16;16;16	C;A;C	16;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	515	1076	evgS	3594	105	100.0	evgS.l6.c30.ctg.2	145	11.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	531	262	folP_1	849	824	99.27	folP_1.l6.c4.ctg.1	1022	12.6	0	.	p	.	0	L10Q	NONSYN	28	30	CTG	3	5	CAG	2;2;3	C;A;G	1;0;3	.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	531	262	folP_1	849	824	99.27	folP_1.l6.c4.ctg.1	1022	12.6	1	SNP	p	P64R	0	.	.	190	192	CCA	165	167	CCA	12;12;13	C;C;A	12;12;13	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	531	262	folP_1	849	824	99.27	folP_1.l6.c4.ctg.1	1022	12.6	1	SNP	p	P64H	0	.	.	190	192	CCA	165	167	CCA	12;12;13	C;C;A	12;12;13	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	531	262	folP_1	849	824	99.27	folP_1.l6.c4.ctg.1	1022	12.6	1	SNP	p	P64A	0	.	.	190	192	CCA	165	167	CCA	12;12;13	C;C;A	12;12;13	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	531	262	folP_1	849	824	99.27	folP_1.l6.c4.ctg.1	1022	12.6	1	SNP	p	P64L	0	.	.	190	192	CCA	165	167	CCA	12;12;13	C;C;A	12;12;13	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	531	262	folP_1	849	824	99.27	folP_1.l6.c4.ctg.1	1022	12.6	1	SNP	p	P64S	0	.	.	190	192	CCA	165	167	CCA	12;12;13	C;C;A	12;12;13	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	224	gadE	528	528	100.0	gadE.l15.c4.ctg.1	968	12.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	84	gadW	729	76	98.68	gadW.l6.c30.ctg.1	136	11.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	84	gadW	729	332	93.07	gadW.l6.c30.ctg.2	332	5.4	0	.	p	.	0	L46P	NONSYN	136	138	CTG	11	13	CCG	1;1;2	C;C;G	1;1;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	84	gadW	729	332	93.07	gadW.l6.c30.ctg.2	332	5.4	0	.	p	.	0	E54D	NONSYN	160	162	GAA	35	37	GAT	2;4;4	G;A;T	2;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	84	gadW	729	332	93.07	gadW.l6.c30.ctg.2	332	5.4	0	.	p	.	0	I88M	NONSYN	262	264	ATA	137	139	ATG	6;6;6	A;T;G	6;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	84	gadW	729	332	93.07	gadW.l6.c30.ctg.2	332	5.4	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	140	142	CCG	6;6;6	C;C;G	6;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	84	gadW	729	332	93.07	gadW.l6.c30.ctg.2	332	5.4	0	.	p	.	0	D100E	NONSYN	298	300	GAC	173	175	GAA	1;1;1	G;A;A	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	84	gadW	729	332	93.07	gadW.l6.c30.ctg.2	332	5.4	0	.	p	.	0	P101S	NONSYN	301	303	CCC	176	178	TCC	1;1;1	T;C;C	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	84	gadW	729	332	93.07	gadW.l6.c30.ctg.2	332	5.4	0	.	p	.	0	R102G	NONSYN	304	306	CGG	179	181	GGG	1;1;1	G;G;G	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	84	gadW	729	332	93.07	gadW.l6.c30.ctg.2	332	5.4	0	.	p	.	0	K110N	NONSYN	328	330	AAA	203	205	AAT	3;3;3	A;A;T	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	196	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1061	9.8	0	.	p	.	0	F53L	NONSYN	157	159	TTC	334	336	TTA	7;7;8	T;T;A	7;7;8	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	196	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1061	9.8	0	.	p	.	0	V79I	NONSYN	235	237	GTT	412	414	ATT	7;7;7	A;T;T	7;7;7	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	196	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1061	9.8	0	.	p	.	0	R246G	NONSYN	736	738	AGA	913	915	GGA	4;4;4	G;G;A	4;4;4	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	196	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1061	9.8	0	.	p	.	0	S248P	NONSYN	742	744	TCG	919	921	CCG	4;4;4	C;C;G	4;4;4	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1056	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2893	19.3	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2102	2104	GAA	13;14;14	G;A;A	13;13;13	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1056	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2893	19.3	1	SNP	p	S83L	0	.	.	247	249	TCG	317	319	TCG	15;15;13	T;C;G	15;15;13	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1056	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2893	19.3	1	SNP	p	S83I	0	.	.	247	249	TCG	317	319	TCG	15;15;13	T;C;G	15;15;13	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1056	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2893	19.3	1	SNP	p	S83W	0	.	.	247	249	TCG	317	319	TCG	15;15;13	T;C;G	15;15;13	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1056	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2893	19.3	1	SNP	p	D87N	0	.	.	259	261	GAC	329	331	GAC	15;16;16	G;A;C	15;16;16	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1056	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2893	19.3	1	SNP	p	D87V	0	.	.	259	261	GAC	329	331	GAC	15;16;16	G;A;C	15;16;16	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1056	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2893	19.3	1	SNP	p	D87H	0	.	.	259	261	GAC	329	331	GAC	15;16;16	G;A;C	15;16;16	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1056	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2893	19.3	1	SNP	p	D87G	0	.	.	259	261	GAC	329	331	GAC	15;16;16	G;A;C	15;16;16	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1056	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2893	19.3	1	SNP	p	D87Y	0	.	.	259	261	GAC	329	331	GAC	15;16;16	G;A;C	15;16;16	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	1	842	gyrB_1	2415	1142	99.65	gyrB_1.l6.c17.ctg.1	1335	15.7	1	SNP	p	R136E	0	.	.	406	408	CGC	599	601	CGC	17;17;17	C;G;C	17;17;17	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	1	842	gyrB_1	2415	1142	99.65	gyrB_1.l6.c17.ctg.1	1335	15.7	1	SNP	p	R136G	0	.	.	406	408	CGC	599	601	CGC	17;17;17	C;G;C	17;17;17	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	1	842	gyrB_1	2415	1142	99.65	gyrB_1.l6.c17.ctg.1	1335	15.7	1	SNP	p	R136H	0	.	.	406	408	CGC	599	601	CGC	17;17;17	C;G;C	17;17;17	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	1	842	gyrB_1	2415	1142	99.65	gyrB_1.l6.c17.ctg.1	1335	15.7	1	SNP	p	R136L	0	.	.	406	408	CGC	599	601	CGC	17;17;17	C;G;C	17;17;17	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	1	842	gyrB_1	2415	1142	99.65	gyrB_1.l6.c17.ctg.1	1335	15.7	1	SNP	p	R136S	0	.	.	406	408	CGC	599	601	CGC	17;17;17	C;G;C	17;17;17	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	1	842	gyrB_1	2415	1142	99.65	gyrB_1.l6.c17.ctg.1	1335	15.7	1	SNP	p	R136I	0	.	.	406	408	CGC	599	601	CGC	17;17;17	C;G;C	17;17;17	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	1	842	gyrB_1	2415	1142	99.65	gyrB_1.l6.c17.ctg.1	1335	15.7	1	SNP	p	R136C	0	.	.	406	408	CGC	599	601	CGC	17;17;17	C;G;C	17;17;17	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	1	842	gyrB_1	2415	1248	98.64	gyrB_1.l6.c17.ctg.2	1387	16.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	168	kdpE	678	678	97.94	kdpE.l6.c30.ctg.1	864	10.1	0	.	p	.	0	A72P	NONSYN	214	216	GCG	377	379	CCG	11;11;11	C;C;G	11;11;11	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	168	kdpE	678	678	97.94	kdpE.l6.c30.ctg.1	864	10.1	0	.	p	.	0	R117P	NONSYN	349	351	CGC	512	514	CCC	11;11;11	C;C,G;C	9;1,6;11	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	168	kdpE	678	678	97.94	kdpE.l6.c30.ctg.1	864	10.1	0	.	p	.	0	T123A	NONSYN	367	369	ACC	530	532	GCC	6;6;6	G;C;C	6;6;6	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	330	leuO	945	945	99.26	leuO.l6.c4.ctg.1	1265	13.9	0	.	p	.	0	P9S	NONSYN	25	27	CCA	189	191	TCA	12;12;12	T;C;A	11;12;12	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	156	marA	384	384	99.74	marA.l15.c4.ctg.1	714	11.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	70	marR	435	164	99.39	marR.l6.c30.ctg.1	341	6.3	1	SNP	p	V45E	0	.	.	133	135	GTG	310	312	GTG	10;10;10	G;T;G	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	70	marR	435	164	99.39	marR.l6.c30.ctg.1	341	6.3	1	SNP	p	I49S	0	.	.	145	147	ATC	322	324	ATC	6;6;6	A;T;C	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	70	marR	435	234	97.01	marR.l6.c30.ctg.2	234	5.7	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	113	115	AGC	6;5;5	A;G;C	6;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	70	marR	435	234	97.01	marR.l6.c30.ctg.2	234	5.7	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	215	217	CAT	6;5;5	C;A;T	6;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	70	marR	435	234	97.01	marR.l6.c30.ctg.2	234	5.7	1	SNP	p	A70T	0	.	.	208	210	GCA	14	16	GCA	9;9;9	G;C;A	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	70	marR	435	234	97.01	marR.l6.c30.ctg.2	234	5.7	1	SNP	p	R73C	0	.	.	217	219	CGT	23	25	CGT	9;9;9	C;G;T	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	70	marR	435	234	97.01	marR.l6.c30.ctg.2	234	5.7	1	SNP	p	R73S	0	.	.	217	219	CGT	23	25	CGT	9;9;9	C;G;T	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	70	marR	435	234	97.01	marR.l6.c30.ctg.2	234	5.7	1	SNP	p	R77L	0	.	.	229	231	CGC	35	37	CGC	7;6;6	C;G;C	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	70	marR	435	234	97.01	marR.l6.c30.ctg.2	234	5.7	1	SNP	p	R77C	0	.	.	229	231	CGC	35	37	CGC	7;6;6	C;G;C	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	70	marR	435	234	97.01	marR.l6.c30.ctg.2	234	5.7	1	SNP	p	L78M	0	.	.	232	234	CTG	38	40	CTG	6;6;6	C;T;G	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	70	marR	435	234	97.01	marR.l6.c30.ctg.2	234	5.7	1	SNP	p	R94H	0	.	.	280	282	CGC	86	88	CGC	5;5;5	C;G;C	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	70	marR	435	234	97.01	marR.l6.c30.ctg.2	234	5.7	1	SNP	p	R94S	0	.	.	280	282	CGC	86	88	CGC	5;5;5	C;G;C	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	70	marR	435	234	97.01	marR.l6.c30.ctg.2	234	5.7	1	SNP	p	V96E	0	.	.	286	288	GTA	92	94	GTA	7;7;8	G;T;A	7;7;8	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	250	mdfA	1233	948	97.78	mdfA.l15.c4.ctg.1	1180	10.3	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	58	60	CAG	18;18;17	C;A;G	17;17;16	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	250	mdfA	1233	948	97.78	mdfA.l15.c4.ctg.1	1180	10.3	0	.	p	.	0	D128A	NONSYN	382	384	GAC	97	99	GCC	10;10;10	G;C;C	9;10;10	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	250	mdfA	1233	948	97.78	mdfA.l15.c4.ctg.1	1180	10.3	0	.	p	.	0	S163A	NONSYN	487	489	TCG	202	204	GCG	13;13;15	G;C;G	13;13;15	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	250	mdfA	1233	948	97.78	mdfA.l15.c4.ctg.1	1180	10.3	0	.	p	.	0	L231V	NONSYN	691	693	CTT	406	408	GTT	11;11;11	G,T;T;T	5,1;10;9	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	250	mdfA	1233	948	97.78	mdfA.l15.c4.ctg.1	1180	10.3	0	.	p	.	0	R285fs	FSHIFT	853	853	C	568	568	C	6	C	6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	250	mdfA	1233	86	98.84	mdfA.l15.c4.ctg.3	89	3.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	322	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1441	11.4	0	.	p	.	0	V12trunc	TRUNC	34	34	G	62	62	G	11	G	11	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	322	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1441	11.4	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	119	121	CAG	11;11;10	C;A;G	11;11;10	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	322	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1441	11.4	0	.	p	.	0	T83I	NONSYN	247	249	ACC	269	271	ATC	7;7;7	A;T;C	7;7;7	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	322	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1441	11.4	0	.	p	.	0	I99M	NONSYN	295	297	ATA	317	319	ATG	8;9;10	A;T;G	8;9;10	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	322	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1441	11.4	0	.	p	.	0	A130T	NONSYN	388	390	GCC	410	412	ACC	7;7;6	A;C;C	7;7;6	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1186	mdtB	3123	3123	98.91	mdtB.l15.c30.ctg.1	3353	18.8	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1863	1865	ACC	24;24;26	A;C;C	24;24;26	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1186	mdtB	3123	3123	98.91	mdtB.l15.c30.ctg.1	3353	18.8	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2256	2258	CAA	8;8;8	C;A;A	7;8;7	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1186	mdtB	3123	3123	98.91	mdtB.l15.c30.ctg.1	3353	18.8	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2424	2426	ATT	8;8;8	A;T;T	8;8;8	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1186	mdtB	3123	3123	98.91	mdtB.l15.c30.ctg.1	3353	18.8	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2508	2510	GTT	10;10;10	G;T;T	10;10;10	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1186	mdtB	3123	3123	98.91	mdtB.l15.c30.ctg.1	3353	18.8	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2616	2618	GAG	12;12;12	G;A;G	12;12;12	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1186	mdtB	3123	3123	98.91	mdtB.l15.c30.ctg.1	3353	18.8	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2844	2846	ATG	14;15;13	A;T;G	14;15;13	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1186	mdtB	3123	3123	98.91	mdtB.l15.c30.ctg.1	3353	18.8	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	2979	2981	GAT	24;23;23	G;A;T	23;23;23	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	986	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3162	16.4	0	.	p	.	0	I46M	NONSYN	136	138	ATC	201	203	ATG	7;8;8	A;T;G	7;8;8	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	986	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3162	16.4	0	.	p	.	0	V208I	NONSYN	622	624	GTC	687	689	ATC	21;22;20	A;T;C	20;21;20	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	986	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3162	16.4	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3003	3005	CAC	5;5;5	C;A;C	5;5;5	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	454	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1828	13.3	0	.	p	.	0	D3E	NONSYN	7	9	GAT	222	224	GAA	14;14;14	G;A;A	14;14;14	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	454	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1828	13.3	0	.	p	.	0	T226A	NONSYN	676	678	ACG	891	893	GCG	13;15;13	G;C;G	13;15;13	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	454	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1828	13.3	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1233	1235	ATC	11;11;11	A;T;C	11;11;11	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	454	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1828	13.3	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1536	1538	TTT	10;11;11	T;T;T	10;10;10	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	464	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1591	15.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1160	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3620	17.2	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1133	1135	ACC	13;13;13	A;C,A;C	13;12,1;13	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1160	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3620	17.2	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2375	2377	GAC	14;13;13	G;A;C	14;13;13	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	440	mdtG	1227	742	99.19	mdtG.l15.c4.ctg.1	1017	14.5	0	.	p	.	0	V200I	NONSYN	598	600	GTC	113	115	ATC	22;21;21	A;T;C	22;21;21	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	440	mdtG	1227	166	99.4	mdtG.l15.c4.ctg.2	166	13.3	0	.	p	.	0	E5G	NONSYN	13	15	GAA	4	6	GGA	2;3;5	G;G;A	2;3;5	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	440	mdtG	1227	305	100.0	mdtG.l15.c4.ctg.3	550	8.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	314	mdtH	1209	1166	98.37	mdtH.l15.c4.ctg.1	1351	12.1	0	.	p	.	0	G134C	NONSYN	400	402	GGT	582	584	TGT	11;11;11	T;G;T	11;11;11	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	314	mdtH	1209	1166	98.37	mdtH.l15.c4.ctg.1	1351	12.1	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1152	1154	TTG	11;11;11	T;T;G	11;11;11	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	314	mdtH	1209	1166	98.37	mdtH.l15.c4.ctg.1	1351	12.1	0	.	p	.	0	L359Q	NONSYN	1075	1077	CTG	1257	1259	CAG	9;9;9	C;A;G	9;9;8	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	430	mdtL	1176	1176	98.47	mdtL.l15.c4.ctg.1	1498	15.2	0	.	p	.	0	A185S	NONSYN	553	555	GCC	725	727	TCC	9;9;9	T;C;C	8;9;9	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	667	288	mdtN	1032	1032	98.26	mdtN.l15.c30.ctg.1	1444	10.5	0	.	p	.	0	V119I	NONSYN	355	357	GTT	580	582	ATT	8;8;8	A;T;T	8;8;8	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	667	288	mdtN	1032	1032	98.26	mdtN.l15.c30.ctg.1	1444	10.5	0	HET	.	.	.	G477T	.	477	477	G	702	702	G	14	G,T	2,10	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	690	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2343	15.6	0	.	p	.	0	V11M	NONSYN	31	33	GTG	79	81	ATG	4;5;5	A;T;G	4;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	690	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2343	15.6	0	.	p	.	0	T33I	NONSYN	97	99	ACC	145	147	ATC	6;8;8	A;T;C	6;8;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	690	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2343	15.6	0	.	p	.	0	C116R	NONSYN	346	348	TGC	394	396	CGC	28;27;26	C;G;C	27;27;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	690	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2343	15.6	0	.	p	.	0	N238S	NONSYN	712	714	AAC	760	762	AGC	21;21;22	A;G;C	21;20;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	690	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2343	15.6	0	.	p	.	0	M305V	NONSYN	913	915	ATG	961	963	GTG	9;10;9	G;T;G	9;9;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	690	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2343	15.6	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1024	1026	AAC	4;4;3	A;A;C	4;3;3	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	690	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2343	15.6	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1069	1071	GTC	12;12;12	G;T,C;C	12;11,1;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	690	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2343	15.6	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1099	1101	ATA	9;9;10	A;T;A	9;9;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	690	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2343	15.6	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1207	1209	TCT	13;13;13	T;C;T	13;13;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	690	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2343	15.6	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1594	1596	GCG	23;22;22	G;C;G	23;21;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	690	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2343	15.6	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1807	1809	ATC	9;9;9	A;T;C	9;9;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1743	12.5	0	.	p	.	0	S129A	NONSYN	385	387	TCA	454	456	GCG	12;13;12	G;C;G	12;13;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1743	12.5	0	.	p	.	0	A187T	NONSYN	559	561	GCC	628	630	ACC	12;12;12	A;C;C	12;12;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1743	12.5	0	.	p	.	0	H211R	NONSYN	631	633	CAC	700	702	CGC	13;13;12	C;G;C	13;13;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1743	12.5	0	.	p	.	0	V250A	NONSYN	748	750	GTT	817	819	GCT	16;17;17	G;C;T	16;17;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1743	12.5	0	.	p	.	0	R278K	NONSYN	832	834	AGA	901	903	AAA	9;8;8	A;A;A	9;8;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1743	12.5	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	919	921	CGA	8;8;8	C;G;A	8;8;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1743	12.5	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1084	1086	GCC	10;10;10	G;C;C	10;9;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1743	12.5	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1096	1098	GAT	12;12;13	G;A;T	12;12;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1743	12.5	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1513	1515	GCT	4;2;2	G;C;T	4;2;2	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1176	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3859	16.4	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1493	1495	AAG	6;6;6	A;A;G	6;6;6	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1176	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3859	16.4	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2570	2572	CTG	19;19;17	C;T;G	19;18;17	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	96	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	162	16.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	666	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2082	17.0	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1008	1010	AAC	11;11;12	A;A;C	11;11;12	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	666	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2082	17.0	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1554	1556	ATA	17;17;16	A;T;A	17;17;16	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	434	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1536	14.7	0	.	p	.	0	A343V	NONSYN	1027	1029	GCG	1132	1134	GTG	14;13;14	G;T;G	13;13;13	.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	434	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1536	14.7	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1210	1212	GAT	14;14;14	G;A;T	14;14;14	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	434	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1536	14.7	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1213	1215	CTG	14;14;14	C;T,G;G	14;13,1;14	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	226	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1016	11.4	0	.	p	.	0	R27C	NONSYN	79	81	CGT	179	181	TGT	12;12;13	T;G;T	12;12;13	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	226	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1016	11.4	0	.	p	.	0	I117T	NONSYN	349	351	ATC	449	451	ACC	17;18;18	A,C;C;C	16,1;18;18	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	226	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1016	11.4	0	.	p	.	0	G187D	NONSYN	559	561	GGC	659	661	GAC	10;10;10	G;A;C	10;10;10	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	226	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1016	11.4	1	SNP	p	R15C	0	.	.	43	45	CGC	143	145	CGC	17;17;17	C;G;C	17;17;17	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	226	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1016	11.4	1	SNP	p	S33R	0	.	.	97	99	AGC	197	199	AGC	11;11;11	A;G;C	11;11;11	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	226	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1016	11.4	1	SNP	p	G131D	0	.	.	391	393	GGC	491	493	GGC	17;17;17	G;G;C	17;17;16	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	226	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1016	11.4	1	SNP	p	R203L	0	.	.	607	609	CGT	707	709	CGT	13;14;14	C;G;T	12;13;14	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	226	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1016	11.4	1	SNP	p	R203C	0	.	.	607	609	CGT	707	709	CGT	13;14;14	C;G;T	12;13;14	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	530	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1530	18.5	1	SNP	p	G141D	0	.	.	421	423	GGT	640	642	GGT	23;23;23	G;G;T	23;22;23	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	530	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1530	18.5	1	SNP	p	G141E	0	.	.	421	423	GGT	640	642	GGT	23;23;23	G;G;T	23;22;23	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	530	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1530	18.5	1	SNP	p	R154D	0	.	.	460	462	CGT	679	681	CGT	22;22;20	C;G;T	22;22;20	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	530	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1530	18.5	1	SNP	p	R154A	0	.	.	460	462	CGT	679	681	CGT	22;22;20	C;G;T	22;22;20	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	846	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2729	16.6	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1886	1888	TCG	19;19;19	T;C;G	19;19;19	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	846	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2729	16.6	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2501	2503	AAC	8;7;7	A;A;C	8;7;7	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	846	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2729	16.6	1	SNP	p	A85T	0	.	.	253	255	GCG	515	517	GCG	19;16;17	G;C;G	19;16;17	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	846	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2729	16.6	1	SNP	p	D111H	0	.	.	331	333	GAT	593	595	GAT	16;16;16	G;A;T	16;16;16	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	846	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2729	16.6	1	SNP	p	S129P	0	.	.	385	387	TCC	647	649	TCC	20;20;20	T;C;C	20;20;20	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	536	parE_1	1893	756	98.54	parE_1.l6.c4.ctg.1	925	14.5	1	SNP	p	D476N	0	.	.	1426	1428	GAT	289	291	GAT	13;14;13	G;A;T	13;14;13	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	536	parE_1	1893	947	96.73	parE_1.l6.c4.ctg.2	947	12.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	536	parE_1	1893	166	96.99	parE_1.l6.c4.ctg.3	206	10.7	0	.	p	.	0	H51P	NONSYN	151	153	CAC	169	171	CCC	1;1;1	C;C;C	0;0;0	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	536	parE_1	1893	166	96.99	parE_1.l6.c4.ctg.3	206	10.7	0	.	p	.	0	R54P	NONSYN	160	162	CGC	178	180	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	518	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1848	15.0	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1351	1353	GAT	17;17;16	G;A;T	17;17;16	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	518	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1848	15.0	0	.	p	.	0	Q411H	NONSYN	1231	1233	CAG	1504	1506	CAT	15;16;16	C;A;T	14;16;16	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	1516	rpoB	4029	4029	99.01	rpoB.l6.c30.ctg.1	4407	18.5	0	.	p	.	0	L533R	NONSYN	1597	1599	CTC	1820	1822	CGC	13;13;14	C;G,T;C	13;11,2;14	.	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	1516	rpoB	4029	4029	99.01	rpoB.l6.c30.ctg.1	4407	18.5	1	SNP	p	V146F	0	.	.	436	438	GTT	659	661	GTT	12;11;10	G;T;T	12;11;10	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	1516	rpoB	4029	4029	99.01	rpoB.l6.c30.ctg.1	4407	18.5	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1760	1762	CAG	23;24;24	C;A;G	23;24;24	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	1516	rpoB	4029	4029	99.01	rpoB.l6.c30.ctg.1	4407	18.5	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1760	1762	CAG	23;24;24	C;A;G	23;24;24	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	1516	rpoB	4029	4029	99.01	rpoB.l6.c30.ctg.1	4407	18.5	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1799	1801	CAC	20;20;20	C;A;C	20;20;20	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	1516	rpoB	4029	4029	99.01	rpoB.l6.c30.ctg.1	4407	18.5	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1808	1810	CGT	21;20;20	C;G;T	21;20;20	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	1516	rpoB	4029	4029	99.01	rpoB.l6.c30.ctg.1	4407	18.5	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1808	1810	CGT	21;20;20	C;G;T	21;20;20	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	1516	rpoB	4029	4029	99.01	rpoB.l6.c30.ctg.1	4407	18.5	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1814	1816	TCC	16;14;14	T;C;C	16;14;14	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	1516	rpoB	4029	4029	99.01	rpoB.l6.c30.ctg.1	4407	18.5	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1910	1912	ACC	17;17;17	A;C;C	17;17;17	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	1516	rpoB	4029	4029	99.01	rpoB.l6.c30.ctg.1	4407	18.5	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1913	1915	CCT	20;21;21	C;C;T	20;21;21	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	539	1516	rpoB	4029	4029	99.01	rpoB.l6.c30.ctg.1	4407	18.5	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2282	2284	CGT	24;24;23	C;G;T	23;24;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.2	517	135.9	1	SNP	n	A1519G	0	.	.	1519	1519	A	480	480	A	71	A	70	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.2	517	135.9	1	SNP	n	A1519T	0	.	.	1519	1519	A	480	480	A	71	A	70	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.2	517	135.9	1	SNP	n	A1519C	0	.	.	1519	1519	A	480	480	A	71	A	70	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.3	1161	114.5	0	.	n	.	0	A226G	SNP	226	226	A	386	386	G	148	G	147	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.3	1161	114.5	1	SNP	n	A794G	0	.	.	794	794	A	954	954	A	111	A	108	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.3	1161	114.5	1	SNP	n	A794T	0	.	.	794	794	A	954	954	A	111	A	108	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.3	1161	114.5	1	SNP	n	G926A	0	.	.	926	926	G	1086	1086	G	129	G	129	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.3	1161	114.5	1	SNP	n	G926T	0	.	.	926	926	G	1086	1086	G	129	G	129	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.3	1161	114.5	1	SNP	n	G926C	0	.	.	926	926	G	1086	1086	G	129	G	129	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.3	1161	114.5	0	HET	.	.	.	C194T	.	194	194	C	354	354	C	123	C,T	94,29	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.3	1161	114.5	0	HET	.	.	.	A250T	.	250	250	A	410	410	A	112	A,T	93,18	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.3	1161	114.5	0	HET	.	.	.	A79G	.	79	79	A	239	239	A	112	A,G	85,27	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.3	1161	114.5	0	HET	.	.	.	C719T	.	719	719	C	879	879	C	134	C,T	81,52	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.3	1161	114.5	0	HET	.	.	.	T273A	.	273	273	T	433	433	T	94	T,A	76,16	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.3	1161	114.5	0	HET	.	.	.	G474A	.	474	474	G	634	634	G	137	G,A	102,33	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.3	1161	114.5	0	HET	.	.	.	C183T	.	183	183	C	343	343	C	110	C,T	66,43	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.3	1161	114.5	0	HET	.	.	.	T90C	.	90	90	T	250	250	T	106	T,C	79,26	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.3	1161	114.5	0	HET	.	.	.	A253T	.	253	253	A	413	413	A	109	A,T	90,18	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	140	100.0	rrsB+.l15.c30.ctg.5	140	32.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	143	95.14	rrsB+.l15.c30.ctg.6	143	13.8	0	.	n	.	0	G1002A	SNP	1002	1002	G	54	54	A	28	A	28	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	143	95.14	rrsB+.l15.c30.ctg.6	143	13.8	0	.	n	.	0	G1006C	SNP	1006	1006	G	58	58	C	28	C	28	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	143	95.14	rrsB+.l15.c30.ctg.6	143	13.8	0	.	n	.	0	T1010C	SNP	1010	1010	T	62	62	C	27	C	26	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	143	95.14	rrsB+.l15.c30.ctg.6	143	13.8	0	.	n	.	0	A1019.	DEL	1019	1019	A	70	70	G	25	G	25	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	143	95.14	rrsB+.l15.c30.ctg.6	143	13.8	0	.	n	.	0	.1023G	INS	1023	1023	T	75	75	G	24	G	24	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4214	rrsB+	1542	143	95.14	rrsB+.l15.c30.ctg.6	143	13.8	0	.	n	.	0	C1038T	SNP	1038	1038	C	90	90	T	16	T	16	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	19	184	soxR	465	425	100.0	soxR.l15.c4.ctg.1	596	15.3	1	SNP	p	R20H	0	.	.	58	60	CGC	196	198	CGC	18;18;17	C;G;C	18;18;17	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	19	184	soxR	465	425	100.0	soxR.l15.c4.ctg.1	596	15.3	1	SNP	p	G121D	0	.	.	361	363	GGT	499	501	GGT	24;24;24	G;G;T	23;24;24	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	150	soxS_1	324	324	99.69	soxS_1.l6.c4.ctg.1	668	11.7	1	SNP	p	A12S	0	.	.	34	36	GCA	219	221	GCA	21;22;23	G;C;A	21;22;23	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	539	560	tolC	1488	1488	98.66	tolC.l6.c30.ctg.1	1928	15.6	0	.	p	.	0	A58S	NONSYN	172	174	GCG	429	431	TCG	19;19;20	T,G;C;G	18,1;19;19	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
